Reprint of article from Tablets and Capsules Magazine - March, 2006. Copyright, CSC Publishing.
Pharmaceutical companies outsource the preparation of clinical trial materials (CTMs) to pharmaceutical development organizations (PDOs) for many reasons. Sometimes, a company (called a sponsor) seeks to avoid investing in specialized equipment or personnel. Sometimes, the PDOs have a desirable niche expertise. But in almost all cases, time is the driving force. See rest of article